General MedicationsINJECTIONStandard
TRULICITY
DULAGLUTIDE
Standard Dose
0.75MG/0.5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TRULICITY is listed in Drugs@FDA under application 125469 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DULAGLUTIDE Form and strength INJECTABLE;INJECTION - 0.75MG/0.5ML Sponsor ELI LILLY AND CO Submission history Latest submission status date: 2026-03-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview TRULICITY is listed in Drugs@FDA under application 125469 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient DULAGLUTIDE Form and strength INJECTABLE;INJECTION - 0.75MG/0.5ML Sponsor ELI LILLY AND CO Submission history Latest submission status date: 2026-03-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.